Search Prime Contracts

75F40123C00073

Definitive Contract
'Game Changing Market Intel'

HigherGov subscribers won more than $120 Billion in government awards last year

Free Trial Schedule Demo

Overview

Government Description
UEI: HCWKVFGBPA64 LABOR HOUR AWARD CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) OFFICE OF NEW DRUGS (OND) - WRITER/EDITOR SUPPORT SERVICES COR: NIKISHA REID PHONE: 240-402-9741, NIKISHA.REID@FDA.HHS.GOV NOTICE TO PROCEED WAS ISSUED ON 05/30
Awardee
Kaiva Strategies
Awarding / Funding Agency
FDA Office of Acquisition and Grant Services (OAGS) [HHS - FDA]
NAICS
541690 - Other Scientific and Technical Consulting Services
PSC
R406 - Support- Professional: Policy Review/Development
Place of Performance
Rockville, MD 20857 United States
Pricing
Labor Hours
Set Aside
None
Extent Competed
Not Available For Competition
Related Opportunity
None
Analysis Notes
COVID-19 $1,171,895 (16%) percent of this Definitive Contract was funded by COVID-19 emergency acts including the American Rescue Plan Act of 2021.
Sole Source This Definitive Contract was awarded sole source to Kaiva Strategies because the government was authorized to sole source the contract by statute.
Undisclosed Subcontractors No subcontract awards have been formally disclosed for this contract; however, based on invoice data these subcontractors have worked on this contract: DRT Strategies
Kaiva Strategies was awarded Definitive Contract 75F40123C00073 (75F401-23-C-00073) worth up to $9,999,433 by the FDA Office of Acquisition and Grant Services in September 2023. The contract has a duration of 1 year 2 months and was awarded full & open with NAICS 541690 and PSC R406 via sole source acquisition procedures with 1 bid received. As of today, the Definitive Contract has a total reported backlog of $2,644,453.

Status
(Open)

Last Modified 11/13/23
Period of Performance
9/5/23
Start Date
11/30/24
Current End Date
11/30/24
Potential End Date
86.0% Complete

Obligations and Backlog
$7.4M
Total Obligated
$7.4M
Current Award
$10.0M
Potential Award
74% Funded
$0.0
Funded Backlog
$2.6M
Total Backlog

Award Hierarchy

Definitive Contract

75F40123C00073

Subcontracts

0

Activity Timeline

Interactive chart of timeline of amendments to 75F40123C00073

Labor Services Billing

Annual labor billing rates and FTE reported for 75F40123C00073

Year Services Invoiced Hours FTE Blended Rate
2023 $1,258,661 13,764.5 6.6 $91.44

Transaction History

Modifications to 75F40123C00073

People

Suggested agency contacts for 75F40123C00073

Competition

Number of Bidders
1
Solicitation Procedures
Sole Source
Other Than Full and Open Competition
Authorized By Statute
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
No

Other Categorizations

Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Awardee UEI
HCWKVFGBPA64
Awardee CAGE
99AZ4
Agency Detail
Awarding Office
75F401 FDA OFFICE OF ACQ GRANT SVCS
Funding Office
75F401
Created By
hhsjwilliams
Last Modified By
hhsjwilliams
Approved By
hhsjwilliams

Legislative

Legislative Mandates
None Applicable
Performance District
MD-08
Senators
Benjamin Cardin
Chris Van Hollen
Representative
Jamie Raskin

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
Salaries and Expenses, Food and Drug Administration, Health and Human Services (075-0600) Consumer and occupational health and safety Other services from non-Federal sources (25.2) $2,437,541 100%
Modified: 11/13/23